Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China-Reference-Cited by-同舟云学术

Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China

Published:2023-01-03 Issue:1 Volume:12 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Xu Hongqin¹,Li Hongyan²,You Hailong³,Zhang Peng⁴,Li Nan⁵,Jiang Nan⁶,Cao Yang⁷,Qin Ling⁸,Qin Guixiang⁹,Qu Hongbo¹⁰,Wang Heyuan¹¹,Zou Bo¹²,He Xia¹³,Li Dan¹⁴,Zhao Huazhong¹⁵,Huang Gang¹⁶,Li Yang¹⁴,Zhang Hefeng¹⁵,Zhu Liping¹⁷,Qiao Hongmei¹⁸,Li Hongjun¹⁹,Liu Shurong²⁰,Gu Lina⁵,Yin Guidong²¹,Hu Ye²⁰,Xu Songbai²²,Guo Weiying¹¹,Wang Nanya²³,Liu Chaoying¹⁴,Gao Pujun¹,Cao Jie²⁴,Zheng Yang⁸,Zhang Kaiyu⁴,Wang Yang⁴,Chen Hui²⁰,Zhang Jian⁶,Mu Dongmei²⁵,Niu Junqi¹

Affiliation:

1. Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, People’s Republic of China

2. Nursing Department, The First Hospital of Jilin University, Changchun, People’s Republic of China

3. Department of Pediatrics, First Hospital of Jilin University, Changchun, People’s Republic of China

4. Department of Infectious Diseases, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, People’s Republic of China

5. Intensive Care Unit, The First Hospital of Jilin University, Changchun, People’s Republic of China

6. Department of Infectious Diseases, Changchun Infectious Disease Hospital, Changchun, People’s Republic of China

7. Department of obstetrics and gynecology, Hepatobiliary Hospital of Jilin, Changchun, People’s Republic of China

8. Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, People’s Republic of China

9. Center of Tubercular Meningitis, Changchun Infectious Disease Hospital, Changchun, People’s Republic of China

10. Department of Medical Affairs, Hepatobiliary Hospital of Jilin, Changchun, People’s Republic of China

11. Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, People’s Republic of China

12. Department of Medical Affairs, Changchun Infectious Disease Hospital, Changchun, People’s Republic of China

13. Nursing Department, Hepatobiliary Hospital of Jilin, Changchun, People’s Republic of China

14. Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun, People’s Republic of China

15. Department of Integrated Traditional and Western Medicine, Changchun Infectious Disease Hospital, Changchun, People’s Republic of China

16. Center of Information and Statistics, Hepatobiliary Hospital of Jilin, Changchun, People’s Republic of China

17. Department of Integrated Traditional and Western Medicine, Hepatobiliary Hospital of Jilin, Changchun, People’s Republic of China

18. Department of pediatric respiratory medicine, The First Hospital of Jilin University, Changchun, People’s Republic of China

19. The Fifth treatment area, Changchun Infectious Disease Hospital, Changchun, People’s Republic of China

20. Department of Hepatology, Hepatobiliary Hospital of Jilin, Changchun, People’s Republic of China

21. Department of cerebral surgery, Changchun Infectious Disease Hospital, Changchun, People’s Republic of China

22. Department of Neurosurgery, the First Hospital of Jilin University, Changchun, People’s Republic of China

23. Cancer Center, The First Hospital of Jilin University, Changchun, People’s Republic of China

24. Department of Neology, The First Hospital of Jilin University, Changchun, People’s Republic of China

25. Department of Clinical Epidemiology, The First Hospital of Jilin University, Changchun, People’s Republic of China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2149935

Reference37 articles.

1. Organization WH. (2022). WHO Coronavirus (COVID-19) Dashboard. 2022: https://covid19.who.int/.

2. Organization WH. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. 2021: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.

3. Omicron likely to weaken COVID vaccine protection

4. How bad is Omicron? What scientists know so far

5. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc-empowered exosomes with superior epithelial layer transmission and lung distribution ability for pulmonary vaccination;Bioactive Materials;2024-12

2. Visceral Adiposity and Neutralizing Antibody Expression: An Adult-Based Cross-Sectional Study;Journal of Inflammation Research;2024-08

3. Prevalence and influencing factors of sleep disorders in medical students after the COVID-19 pandemic;BMC Psychiatry;2024-07-30

4. An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals;Scientific Reports;2024-07-24

5. Efficacy of the tetravalent protein COVID-19 vaccine, SCTV01E: a phase 3 double-blind, randomized, placebo-controlled trial;Nature Communications;2024-07-24